Back to the portfolio

Directional electroporation catheter for targeted vascular

Biomedical DevicesPrototype likely

This technology is a balloon catheter that uses precisely controlled electrical pulses to destroy diseased tissue inside blood vessels — for example, the buildup that causes artery narrowing — without generating damaging heat. The catheter carries multiple independently controllable electrodes arranged around its surface, so a physician can activate only the electrodes that face the diseased tissue while leaving the healthy side of the vessel wall untreated. This selective firing pattern is the key innovation: existing electroporation catheters treat the full circumference of a vessel, which wastes energy and risks harming healthy tissue when a blockage only covers part of the vessel wall. The device is already granted, and the method claim is broad enough to cover a wide range of electrode selection sequences and pulse parameters.

What you could build

A next-generation peripheral or coronary atherectomy/debulking catheter sold to interventional cardiologists and vascular surgeons, competing with or complementing existing drug-coated balloon and atherectomy systems by offering non-thermal, spatially targeted tissue ablation.

Who in Virginia should care

Interventional cardiology device companies, contract medical device manufacturers, and hospital systems with large vascular surgery programs — such as Inova, VCU Health, or UVA Health — would be plausible partners or licensees.

Readiness: Prototype likely

Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.

Readiness is inferred from the patent text, not from a lab visit.

The record

Inventors
Robert E. Neal, Paulo A. Garcia, Rafael V. Davalos, Peter Callas
Granted
February 25, 2025
Status
Granted patent
Patent number
12232792

Ready to talk?

Virginia Tech Intellectual Properties handles licensing for this technology.

VTIP contact coming shortly

Prosim summaries are generated from public patent text and are not legal advice.